Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.

Hadinger KP, Marshalek JP, Sheeran PS, Dayton PA, Matsunaga TO. "Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells." Ultrasound Med Biol. 2018;44(12):2728-2738.